0000950138-18-000574.txt : 20181023
0000950138-18-000574.hdr.sgml : 20181023
20181023192247
ACCESSION NUMBER: 0000950138-18-000574
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20181020
FILED AS OF DATE: 20181023
DATE AS OF CHANGE: 20181023
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Urbanek David Alan
CENTRAL INDEX KEY: 0001752446
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38661
FILM NUMBER: 181135094
MAIL ADDRESS:
STREET 1: 2500 INNOVATION WAY
CITY: GREENFIELD
STATE: IN
ZIP: 46140
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Elanco Animal Health Inc
CENTRAL INDEX KEY: 0001739104
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: IN
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2500 INNOVATION WAY
CITY: GREENFIELD
STATE: IN
ZIP: 46140
BUSINESS PHONE: 877-352-6261
MAIL ADDRESS:
STREET 1: 2500 INNOVATION WAY
CITY: GREENFIELD
STATE: IN
ZIP: 46140
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2018-10-20
0001739104
Elanco Animal Health Inc
ELAN
0001752446
Urbanek David Alan
C/O ELANCO ANIMAL HEALTH INCORPORATED
2500 INNOVATION WAY
GREENFIELD
IN
46140
0
1
0
0
See Remarks
Common Stock
2018-10-20
4
A
0
6979
0
A
7479
D
Non-Qualified Stock Option (Right-to-Buy)
31.61
2018-10-20
4
A
0
21086
A
2028-10-20
Elanco Animal Health Inc. Common Stock
21086
21086
D
Grant of restricted stock units pursuant to the 2018 Elanco Stock Plan on October 20, 2018, vesting on October 20, 2021.
Grant of stock option pursuant to the 2018 Elanco Stock Plan on October 20, 2018, vesting on October 20, 2021.
Executive Vice President, Manufacturing and Quality. Exhibit 24 - Power of Attorney for David A. Urbanek
/s/ Darlene Quashie Henry, as Attorney-in-Fact for David A. Urbanek
2018-10-23
EX-24
2
urbanekpoa.txt
POWER OF ATTORNEY FOR DAVID URBANEK
POWER OF ATTORNEY
October 23, 2018
Know all by these present, that the undersigned hereby constitutes and
appoints Darlene Quashie Henry, with full power of substitution, the
undersigned's true and lawful attorney-in-fact to:
(1) execute for and on behalf of the undersigned, in the undersigned's
capacity as an officer and/or director of Elanco Animal Health
Incorporated (the "Company") or as a stockholder of the Company or as a
trustee of a stockholder of the Company, Forms 3, 4, and 5 and
Schedules 13D or 13G, including amendments thereto, relating to the
securities of the Company in accordance with Section 16(a) of the
Securities Exchange Act of 1934 and the rules thereunder;
(2) do and perform any and all acts for and on behalf of the undersigned
which may be necessary or desirable to complete and execute any such
Form 3, 4, or 5 or Schedule 13D or 13G, complete and execute any
amendment or amendments thereto, and timely file such form with the
United States Securities and Exchange Commission and any stock exchange
or similar authority; and
(3) take any other action of any type whatsoever in connection with the
foregoing which, in the opinion of such attorney-in-fact, may be of
benefit to, in the best interest of, or legally required by, the
undersigned, it being understood that the documents executed by such
attorney-in-fact on behalf of the undersigned pursuant to this Power of
Attorney shall be in such form and shall contain such terms and
conditions as such attorney-in-fact may approve in such attorney in
fact's discretion.
The undersigned hereby grants to such attorney-in-fact full power and
authority to do and perform any and every act and thing whatsoever requisite,
necessary, or proper to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as the undersigned might
or could do if personally present, with full power of substitution or
revocation, hereby ratifying and confirming all that such attorney-in-fact, or
such attorney-in-fact's substitute or substitutes, shall lawfully do or cause
to be done by virtue of this Power of Attorney and the rights and powers herein
granted. The undersigned acknowledges that the foregoing attorney-in-fact, in
serving in such capacity at the request of the undersigned, is not assuming,
nor is the Company assuming, any of the undersigned's responsibilities to
comply with, or liabilities that may arise under, Section 16 of the Securities
Exchange Act of 1934.
This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4, and 5 or Schedules 13D or
13G with respect to the undersigned's holdings of and transactions in
securities issued by the Company, unless earlier revoked by the undersigned in
a signed writing delivered to the foregoing attorneys-in-fact.
This Power of Attorney shall not revoke any powers of attorney
previously executed by the undersigned. This Power of Attorney shall not be
revoked by any subsequent power of attorney that the undersigned may execute,
unless such subsequent power of attorney specifically provides that it revokes
this Power of Attorney by referring to the date of the undersigned's execution
of this Power of Attorney.
[The remainder of this page has been intentionally left blank]
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney
to be executed as of the day and year first above written.
David A. Urbanek
___________________
Signature
David A. Urbanek
___________________
Printed Name